EichorEICHOR
Location: Pusan Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Pusan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · Eisai Korea Inc. · NCT06246123This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Walden Biosciences · NCT06466135A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215Double Unit Cord Blood Transplant in Hematologic Malignancies.
Phase N/A · Dong-A University Hospital · Seoul National University Hospital · NCT06712108A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1 · Myeloid Therapeutics · NCT06478693LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Inje University Haeundae Paik Hospital · Eli Lilly and Company · NCT07415044The DECISION-CTO Extended 10 Y Follow-up
Phase N/A · Seung-Jung Park · NCT06908499Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Bayer · NCT07192952A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Regeneron Pharmaceuticals · NCT06091865A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Dong-A University Hospital · Fore Biotherapeutics · NCT05503797A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Pharmaceuticals · NCT07357727A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Loxo Oncology, Inc. · NCT05254743A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Celgene · NCT05519085Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Gilead Sciences · NCT06051617Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
Phase 3 · Pusan National University Hospital · National Cancer Center, Korea · NCT05827523Phospholipid-rich Dairy Extract for Cognitive Function
NA · Pusan National University Yangsan Hospital · NCT07011680EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Biogen · NCT06962800A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Boehringer Ingelheim · NCT07220083Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Dong-A University Hospital · Kura Oncology, Inc. · NCT07007312Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NA · Kosin University Gospel Hospital · Yonsei University · NCT05490433A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Pusan National University Hospital · Eli Lilly and Company · NCT06338995Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Phase N/A · Novartis Pharmaceuticals · NCT04174157Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
Phase N/A · Inje University Pusan Paik Hospital · Seung-Jung Park · NCT03427996A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
Phase N/A · Novartis Pharmaceuticals · NCT06905288Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Phase N/A · Dong-A Medical Center · Seung-Jung Park · NCT01366404Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical
Phase N/A · Pusan National University Hospital · Duk-Woo Park, MD · NCT04443530
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.